Soil cadmium (Cd) pollution is one of the major environmental problems globally. Ophiopogon japonicus, a multifunctional plant extensively used in traditional Chinese medicine, has demonstrated potential in environmental remediation. This study investigated the Cd accumulation pattern of O. japonicus under cadmium stress and identified the heavy metal ATPase (HMA) family members in this plant. Our results demonstrated that O. japonicus exhibited a Cd enrichment factor (EF) of 2.75, demonstrating strong potential for soil Cd pollution remediation. Nine heavy metal ATPase (HMA) members of P1B-ATPases were successfully identified from the transcriptome data of O. japonicus, with OjHMA1-OjHMA6 classified as the Zn/Co/Cd/Pb-ATPases and OjHMA7-OjHMA9 as the Cu/Ag-ATPases. The expression levels of OjHMA1, OjHMA2, OjHMA3, and OjHMA7 were significantly up-regulated under Cd stress, highlighting their crucial roles in cadmium ion absorption and transport. The topological analysis revealed that these proteins possessed characteristic transmembrane (TM) segments of the family, along with functional A, P, and N domains involved in regulating ion absorption and release. Metal ion-binding sites (M4, M5, and M6) existed on the TM segments. Based on the number of transmembrane domains and the residues at metal ion-binding sites, the plant HMA family members were categorized into three subgroups: P1B-1 ATPases, P1B-2 ATPases, and P1B-4 ATPases. Specifically, the P1B-1 ATPase subgroup included the motifs TM4(CPC), TM5(YN[X]₄P), and TM6(M[XX]SS); the P1B-2 ATPase subgroup featured the motifs TM4(CPC), TM5(K), and TM6(DKTGT); the P1B-4 ATPase subgroup contained the motifs TM4(SPC) and TM6(HE[X]GT), all of which were critical for protein functions. Molecular docking results revealed the importance of conserved sequences such as CPC/SPC, DKTGT, and HE[X]GT in metal ion coordination and stabilization. These findings provide potential molecular targets for enhancing Cd uptake and tolerance of O. japonicus by genetic engineering and lay a theoretical foundation for developing new cultivars with high Cd accumulation capacity.
Cadmium/metabolism* ; Adenosine Triphosphatases/metabolism* ; Ophiopogon/drug effects* ; Soil Pollutants/toxicity* ; Plant Proteins/metabolism* ; Stress, Physiological ; Multigene Family ; Gene Expression Regulation, Plant

Objective To investigate the clinical features,treatments,and prognoses of cerebral venous sinus thrombosis (CVST).Methods A retrospective analysis of clinical data of 90 patients with CVST,admitted to our hospital from January 2012 to December 2016,was performed.Comprehensive analysis of gender,age,risk factors,clinical manifestations,lesion locations,treatments and prognoses was performed.According to selection of clinical treatment options for patients with anticoagulant therapy,these patients were divided into four groups:anti-infection treatment combined with anticoagulant therapy group (n=7),anticoagulant therapy group (n=61),stent thrombectomy combined with anticoagulant therapy group (n=4),and stent thrombectomy combined with local thrombolysis and anticoagulant therapy group (n=18).Results These 90 patients (41 males and 49 females) ranged from 4 to 75 years old.Of these patients,7 were related to infections,27 were related to abnormal blood constituents,16 were related to pregnancy and puerperium,and 6 were related to oral contraceptive.The most common clinical manifestation was headache (n=69,76.70％),followed by epilepsy (n=37,41.11％) and conscious disturbance (n=25,27.78％),and all symptoms could occur isolatedly or simultaneously.The superior sagittal sinus (n=68) and transverse sinus (n=56) appeared to be the most frequent lesion sites.Four patients (57.14％) from antiinfection treatment combined with anticoagulant therapy group,43 patients (70.49％) from anticoagulant treatment group,3 (75％) from stent thrombectomy combined with anticoagulant therapy group,and 15 patients (83.33％) from stent thrombectomy combined with local thrombolysis and anticoagulant therapy group enjoyed significant curative effects.Conclusions The causes of CVST are various,most of which are non-infective;patients with abnormal blood components and women of childbearing age are of high incidence.The clinical manifestations of CVST are complicated and non-specific.The 4 therapeutic methods can improve clinical symptoms effectively;however,anticoagulant therapy is mainly used for patients with mild symptoms;and stent thrombectomy combined with local thrombolysis and anticoagulant therapy can be used for patients with severe CVST,enjoying effective treatment efficacy.